Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects

Inclusion Criteria

• •Adult ≥ 22 years, either gender
• •Subject previously diagnosed with H. pylori infection
• •Subject received and completed FDA approved treatment option
• •Minimum of 4 weeks to one year has lapsed after completion of FDA approved treatment option
• •Subject with a post therapy positive result from a FDA cleared UBT or FDA cleared Fecal Antigen Test
• •Subject will undergo EGD and gastric biopsy as part of routine care to measure H. pylori post-therapy response
• •Biopsy is obtained from antrum and/or corpus and is tested by CRM
• •At least two of the three CRM tests are performed
• •Subject whose EGD with biopsy occurred ≤ 7 days prior to stool collection
• •Willing and able to sign the IRB approved Informed Consent form for this study project